Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 4
2013 4
2014 4
2015 3
2016 2
2017 3
2018 2
2019 1
2020 2
2021 4
2022 15
2023 18

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P, Blennow K, Suárez-Calvet M; Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort. Benedet AL, et al. Among authors: suridjan i. JAMA Neurol. 2021 Dec 1;78(12):1471-1483. doi: 10.1001/jamaneurol.2021.3671. JAMA Neurol. 2021. PMID: 34661615 Free PMC article.
Genetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.
Rodríguez-Fernández B, Vilor-Tejedor N, Arenaza-Urquijo EM, Sánchez-Benavides G, Suárez-Calvet M, Operto G, Minguillón C, Fauria K, Kollmorgen G, Suridjan I, de Moura MC, Piñeyro D, Esteller M, Blennow K, Zetterberg H, De Vivo I, Molinuevo JL, Navarro A, Gispert JD, Sala-Vila A, Crous-Bou M; ALFA study. Rodríguez-Fernández B, et al. Among authors: suridjan i. Alzheimers Res Ther. 2022 Nov 7;14(1):167. doi: 10.1186/s13195-022-01101-9. Alzheimers Res Ther. 2022. PMID: 36345036 Free PMC article.
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
Palmqvist S, Stomrud E, Cullen N, Janelidze S, Manuilova E, Jethwa A, Bittner T, Eichenlaub U, Suridjan I, Kollmorgen G, Riepe M, von Arnim CAF, Tumani H, Hager K, Heidenreich F, Mattsson-Carlgren N, Zetterberg H, Blennow K, Hansson O. Palmqvist S, et al. Among authors: suridjan i. Alzheimers Dement. 2023 Apr;19(4):1204-1215. doi: 10.1002/alz.12751. Epub 2022 Aug 11. Alzheimers Dement. 2023. PMID: 35950735
The potential clinical value of plasma biomarkers in Alzheimer's disease.
Blennow K, Galasko D, Perneczky R, Quevenco FC, van der Flier WM, Akinwonmi A, Carboni M, Jethwa A, Suridjan I, Zetterberg H. Blennow K, et al. Among authors: suridjan i. Alzheimers Dement. 2023 Sep 11. doi: 10.1002/alz.13455. Online ahead of print. Alzheimers Dement. 2023. PMID: 37694991 Review.
Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
Morrow A, Panyard DJ, Deming YK, Jonaitis E, Dong R, Vasiljevic E, Betthauser TJ, Kollmorgen G, Suridjan I, Bayfield A, Van Hulle CA, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Johnson SC, Engelman CD. Morrow A, et al. Among authors: suridjan i. J Alzheimers Dis. 2022;90(2):667-680. doi: 10.3233/JAD-220349. J Alzheimers Dis. 2022. PMID: 36155504 Free PMC article.
Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
Deming Y, Vasiljevic E, Morrow A, Miao J, Van Hulle C, Jonaitis E, Ma Y, Whitenack V, Kollmorgen G, Wild N, Suridjan I, Shaw LM, Asthana S, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Bendlin BB, Lu Q, Engelman CD; Alzheimer's Disease Neuroimaging Initiative. Deming Y, et al. Among authors: suridjan i. Alzheimers Dement. 2023 Aug;19(8):3406-3416. doi: 10.1002/alz.12990. Epub 2023 Feb 16. Alzheimers Dement. 2023. PMID: 36795776
Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening.
Rabe C, Bittner T, Jethwa A, Suridjan I, Manuilova E, Friesenhahn M, Stomrud E, Zetterberg H, Blennow K, Hansson O; Alzheimer's Disease Neuroimaging Initiative† and the Swedish BioFINDER study. Rabe C, et al. Among authors: suridjan i. Alzheimers Dement. 2023 Apr;19(4):1393-1402. doi: 10.1002/alz.12801. Epub 2022 Sep 23. Alzheimers Dement. 2023. PMID: 36150024
Liver-Specific Polygenic Risk Score Is Associated with Alzheimer's Disease Diagnosis.
Panyard DJ, Deming YK, Darst BF, Van Hulle CA, Zetterberg H, Blennow K, Kollmorgen G, Suridjan I, Carlsson CM, Johnson SC, Asthana S, Engelman CD, Lu Q. Panyard DJ, et al. Among authors: suridjan i. J Alzheimers Dis. 2023;92(2):395-409. doi: 10.3233/JAD-220599. J Alzheimers Dis. 2023. PMID: 36744333 Free PMC article.
55 results